NCT04205760

Brief Summary

This is a pilot, randomized, multicenter interventional trial of a combined preoperative oral nutritional support (ONS) and physical exercise therapy in patients planned for elective implantation of a left-ventricular assist device (LVAD). This pilot study pursues to demonstrate the feasibility and safety of a study protocol to optimize the patients' nutritional and physical state to reduce the number of postoperative complications and consequently to ameliorate the patients' outcome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 19, 2019

Completed
2 years until next milestone

Study Start

First participant enrolled

January 2, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2023

Completed
Last Updated

May 26, 2022

Status Verified

May 1, 2022

Enrollment Period

1.5 years

First QC Date

December 18, 2019

Last Update Submit

May 25, 2022

Conditions

Keywords

LVADpreoperative optimizationend-stage heart failurecardiac surgerynutrition therapyexercisecycling

Outcome Measures

Primary Outcomes (7)

  • Comparison of adverse events

    adverse events between groups related to cycling and nutritional complications

    up to 2 weeks before surgery

  • Separation of caloric supplementation

    Separation between groups on prescribed caloric targets

    up to 2 weeks before surgery

  • Separation of protein supplementation

    Separation between groups on prescribed protein targets

    up to 2 weeks before surgery

  • Proportion of interventions received as prescribed

    Proportion of interventions received as prescribed

    up to 2 weeks before surgery

  • Rate of patients recruited per month

    Target: 1.5 patients per month

    up to 18 months

  • Ratio of control patients received physiotherapy

    Ratio of control patients received physiotherapy

    up to 2 weeks before surgery

  • Ratio of control patients received nutritional support

    Ratio of control patients received nutritional support

    up to 2 weeks before surgery

Secondary Outcomes (19)

  • mortality rates at day 30

    day 30 after randomization

  • rates of ICU length of stay

    up to 3 months

  • rates of hospital length of stay

    up to 3 months

  • Mean duration of mechanical ventilation

    up to 3 months

  • Incidence of complications

    up to 3 months

  • +14 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

Standard Care as per local guidelines

Intervention

EXPERIMENTAL

Oral nutrition support (ONS) and bed-cycling before surgery

Combination Product: Nutrition + exercise

Interventions

Nutrition + exerciseCOMBINATION_PRODUCT

Patients will receive preoperative optimization consisting of oral nutrition support (Fresubin 3.2 kcal) and bed-cycling (50 minutes per day) for 5-14 days before surgery.

Also known as: bed cycling, ONS
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Given informed consent
  • Adult patients (≥18 years)
  • Patients undergoing elective LVAD implantation Additional cardiac surgery, such as bypass grafting, or valve repair is permitted

You may not qualify if:

  • Hospital admission \<5 days prior to planned LVAD implantation
  • Patients on ECMO or INTERMACS\<1
  • Patients already receiving nutrition support on hospital admission
  • Enteral nutrition is contraindicated.
  • Pregnant or lactating patients
  • Patients with clinical fulminant hepatic failure
  • Patients with cirrhosis Child's Class C Liver Disease
  • Patients with clinical kidney failure or requiring hemodialysis
  • Known allergy or intolerance to study nutrients
  • Intracranial or spinal process affecting motor function
  • Lower extremity impairments that prevent cycling
  • Disabling neuropsychiatric disorders or language barriers
  • Weight \> 150 kg
  • Enrolment in an industry sponsored randomized trial within the last 30 days (co-enrolment in academic randomized trials will be considered on a case by case basis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Heart Center Bad Oeynhausen

Bad Oeynhausen, North Rhine-Westphalia, Germany

RECRUITING

RWTH Aachen University

Aachen, Germany

RECRUITING

Heart Center Dresden

Dresden, Germany

NOT YET RECRUITING

University Hospital Justus-Liebig University Giessen

Giessen, Germany

NOT YET RECRUITING

University Medical Center Schleswig-Holstein, Campus Kiel

Kiel, Germany

NOT YET RECRUITING

MeSH Terms

Conditions

Motor Activity

Interventions

Nutritional StatusExercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemographyPopulation CharacteristicsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Christian Stoppe, Prof. Dr. med.

    RWTH Aachen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aileen Hill, Dr. med.

CONTACT

Elena Laaf, MSc

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
functional outcome assessor will be blinded to study group allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: National multicenter two-group randomized-controlled, blinded to assessor clinical pilot trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med.

Study Record Dates

First Submitted

December 18, 2019

First Posted

December 19, 2019

Study Start

January 2, 2022

Primary Completion

July 2, 2023

Study Completion

December 2, 2023

Last Updated

May 26, 2022

Record last verified: 2022-05

Locations